Development and validation of LC-MS-based bioanalytical methods for oligonucleotide therapeutics: points to consider

Yuchen Sun1, Kosuke Saito1, Shin-Ichiro Nitta2

  • 1Division of Medicinal Safety Science, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki City, Kanagawa, 210-9501, Japan.

Summary

Analyzing oligonucleotide therapeutics like antisense oligonucleotides and siRNAs requires specialized bioanalytical methods. This paper offers expert recommendations for liquid chromatography-mass spectrometry (LC-MS) to overcome unique challenges in their analysis.

Related Concept Videos